Vaccines as Technology: Innovation, Barriers, and the Public Health

Author:   Ana Santos Rutschman (Villanova University, Pennsylvania)
Publisher:   Cambridge University Press
Edition:   New edition
ISBN:  

9781009125765


Pages:   250
Publication Date:   14 April 2022
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $80.19 Quantity:  
Add to Cart

Share |

Vaccines as Technology: Innovation, Barriers, and the Public Health


Add your own review!

Overview

Full Product Details

Author:   Ana Santos Rutschman (Villanova University, Pennsylvania)
Publisher:   Cambridge University Press
Imprint:   Cambridge University Press
Edition:   New edition
Dimensions:   Width: 15.10cm , Height: 1.20cm , Length: 22.90cm
Weight:   0.300kg
ISBN:  

9781009125765


ISBN 10:   1009125761
Pages:   250
Publication Date:   14 April 2022
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Introduction; 1. Vaccines as instruments of public health; 2. The vaccine development ecosystem; 3. Vaccine development under proprietary paradigms; 4. Access to vaccine technology; 5. Aligning vaccine innovation with public health needs; 6. Vaccines of the future: present and emerging challenges; Conclusion: broader implications for global public health.

Reviews

'Vaccines as Technology - a timely book demonstrating that the battles over COVID vaccine nationalism and equity are not new but are rooted in the legal structure surrounding how vaccines are created, licensed, and sold. The book explores both the well-worn battle ground of intellectual property rights, but also focuses on the power of contract law to either extend or withhold equity in global vaccine distribution. Essential reading for anyone wanting to understand the broader legal and historical contexts behind the problems we face with COVID vaccine distribution.' Kevin Outterson, Professor of Law and N. Neal Pike Scholar in Health and Disability Law, Boston University School of Law and Executive Director of CARB-X 'This important book could not have come at a better time; it will be an invaluable resource for anyone interested in public health, innovation, and preparedness for emerging pathogens.' Lindsay Wiley, Professor of Law, UCLA Law 'Although vaccines prevent more deaths and misery than any other biomedical intervention, as a pharmaceutical product they are uniquely difficult to develop, produce and distribute. To protect the public health, vaccines must be inexpensive enough to protect billions yet efficient enough to be administered only a few times in a lifetime, rendering them less appealing to investors than expensive treatments for chronic illness. In addition, vaccines are difficult to make safely and are a hard sell to healthy people in the face of growing disinformation. Ana Santos Rutschman provides an extremely helpful, comprehensive and timely explanation of these paradoxical challenges, updated with the story of the Covid-19 vaccines and suggestions for paths toward more stability in the vaccine enterprise.' Arthur Allen, Reporter and Editor, Kaiser Health News, Author, Vaccine: the controversial story of medicine's greatest lifesaver (WW Norton); The Fantastic Laboratory of Dr. Weigl (WW Norton)


Author Information

Ana Santos Rutschman is outgoing Assistant Professor of law Saint Louis University and incoming Professor of Law at Villanova University. She was named a Health Law Scholar (2018) and a Bio Intellectual Property Scholar (2017) by the American Society of Law, Medicine & Ethics for her work on vaccine law and policy.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

wl

Shopping Cart
Your cart is empty
Shopping cart
Mailing List